Peter C. Verlander

1.6k total citations
18 papers, 921 citations indexed

About

Peter C. Verlander is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Peter C. Verlander has authored 18 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Genetics and 5 papers in Cancer Research. Recurrent topics in Peter C. Verlander's work include DNA Repair Mechanisms (10 papers), CRISPR and Genetic Engineering (4 papers) and Carcinogens and Genotoxicity Assessment (3 papers). Peter C. Verlander is often cited by papers focused on DNA Repair Mechanisms (10 papers), CRISPR and Genetic Engineering (4 papers) and Carcinogens and Genotoxicity Assessment (3 papers). Peter C. Verlander collaborates with scholars based in United States, Australia and United Kingdom. Peter C. Verlander's co-authors include Arleen D. Auerbach, Sat Dev Batish, Orna Levran, John Gregory, Philip F. Giampietro, Alfred P. Gillio, Christopher G. Mathew, Cindy Eide, John E. Wagner and Betsy Hirsch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Peter C. Verlander

17 papers receiving 899 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter C. Verlander United States 14 695 255 206 132 100 18 921
Marieke Levitus Netherlands 10 973 1.4× 307 1.2× 338 1.6× 127 1.0× 54 0.5× 12 1.1k
Jonathan P. Park United States 19 462 0.7× 267 1.0× 83 0.4× 177 1.3× 39 0.4× 36 898
M. L. Kwee Netherlands 13 426 0.6× 320 1.3× 72 0.3× 59 0.4× 55 0.6× 24 640
Bharati Hukku United States 16 458 0.7× 145 0.6× 84 0.4× 247 1.9× 46 0.5× 29 882
Delphine Ndiaye‐Lobry United States 10 852 1.2× 162 0.6× 92 0.4× 226 1.7× 232 2.3× 16 1.2k
Ilse Chudoba Germany 16 436 0.6× 410 1.6× 149 0.7× 71 0.5× 91 0.9× 36 858
Sabrina Tosi United Kingdom 20 550 0.8× 205 0.8× 125 0.6× 151 1.1× 578 5.8× 52 1.1k
Heather Pierce United States 11 512 0.7× 247 1.0× 134 0.7× 99 0.8× 16 0.2× 16 728
Gaia Roversi Italy 13 592 0.9× 137 0.5× 121 0.6× 131 1.0× 48 0.5× 18 960
Barbara Hutter Germany 16 413 0.6× 180 0.7× 172 0.8× 160 1.2× 42 0.4× 33 751

Countries citing papers authored by Peter C. Verlander

Since Specialization
Citations

This map shows the geographic impact of Peter C. Verlander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Verlander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Verlander more than expected).

Fields of papers citing papers by Peter C. Verlander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter C. Verlander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Verlander. The network helps show where Peter C. Verlander may publish in the future.

Co-authorship network of co-authors of Peter C. Verlander

This figure shows the co-authorship network connecting the top 25 collaborators of Peter C. Verlander. A scholar is included among the top collaborators of Peter C. Verlander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter C. Verlander. Peter C. Verlander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Krasner, Paul & Peter C. Verlander. (2011). Stem cells in dentistry and medicine: the dentist's role.. PubMed. 30(1). 128, 130–4; quiz 135. 5 indexed citations
2.
Sequist, Lecia V., Victoria A. Joshi, Pasi A. Jänne, et al.. (2006). Epidermal Growth Factor ReceptorMutation Testing in the Care of Lung Cancer Patients. Clinical Cancer Research. 12(14). 4403s–4408s. 65 indexed citations
4.
Hanenberg, Helmut, Sat Dev Batish, Karen E. Pollok, et al.. (2002). Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool. Experimental Hematology. 30(5). 410–420. 71 indexed citations
5.
Gregory, John, John E. Wagner, Peter C. Verlander, et al.. (2001). Somatic mosaicism in Fanconi anemia: Evidence of genotypic reversion in lymphohematopoietic stem cells. Proceedings of the National Academy of Sciences. 98(5). 2532–2537. 158 indexed citations
6.
Wajnrajch, Michael P., Joseph M. Gertner, Jadranka Popović, et al.. (2001). Evaluation of Growth and Hormonal Status in Patients Referred to the International Fanconi Anemia Registry. PEDIATRICS. 107(4). 744–754. 81 indexed citations
7.
Crawford, Joanna, Leonarda Ianzano, Michelangelo Savino, et al.. (1999). ThePISSLREGene: Structure, Exon Skipping, and Exclusion as Tumor Suppressor in Breast Cancer. Genomics. 56(1). 90–97. 35 indexed citations
8.
Whitmore, S.A., Chatri Settasatian, Joanna Crawford, et al.. (1998). Characterization and Screening for Mutations of the Growth Arrest-Specific 11 (GAS11) andC16orf3Genes at 16q24.3 in Breast Cancer. Genomics. 52(3). 325–331. 44 indexed citations
9.
Auerbach, Arleen D. & Peter C. Verlander. (1997). Disorders of DNA replication and repair. Current Opinion in Pediatrics. 9(6). 600–616. 28 indexed citations
10.
Levran, Orna, et al.. (1997). Sequence variation in the Fanconi anemia gene  FAA. Proceedings of the National Academy of Sciences. 94(24). 13051–13056. 97 indexed citations
11.
Gillio, Alfred P., Peter C. Verlander, Sat Dev Batish, Philip F. Giampietro, & Arleen D. Auerbach. (1997). Phenotypic Consequences of Mutations in the Fanconi Anemia FAC Gene: An International Fanconi Anemia Registry Study. Blood. 90(1). 105–110. 18 indexed citations
12.
Gillio, Alfred P., Peter C. Verlander, Sat Dev Batish, Philip F. Giampietro, & Arleen D. Auerbach. (1997). Phenotypic Consequences of Mutations in the Fanconi Anemia FAC Gene: An International Fanconi Anemia Registry Study. Blood. 90(1). 105–110. 95 indexed citations
13.
Auerbach, Arleen D., Peter C. Verlander, Kevin Brown, & Johnson M. Liu. (1997). New molecular diagnostic tests for two congenital forms of anemia. Journal of Clinical Laboratory Analysis. 11(1). 17–22. 3 indexed citations
14.
Giampietro, Philip F., Peter C. Verlander, Jessica G. Davis, & Arleen D. Auerbach. (1997). Diagnosis of Fanconi anemia in patients without congenital malformations: An international Fanconi anemia registry study. American Journal of Medical Genetics. 68(1). 58–61. 9 indexed citations
15.
Levran, Orna, Leonid Kruglyak, K. Ranade, et al.. (1996). A locus for Fanconi anemia on 16q determined by homozygosity mapping.. PubMed. 59(2). 377–84. 24 indexed citations
16.
Youssoufian, Hagop, Arleen D. Auerbach, Peter C. Verlander, Viktor Steimle, & Bernard Mach. (1995). Identification of Cytosolic Proteins That Bind to the Fanconi Anemia Complementation Group C Polypeptide in Vitro. Journal of Biological Chemistry. 270(17). 9876–9882. 50 indexed citations
17.
Pavlakis, Steven G., et al.. (1995). Fanconi anemia and moyamoya. Neurology. 45(5). 998–1000. 30 indexed citations
18.
Verlander, Peter C., Masako Udono, Qingjiong Zhang, et al.. (1994). Mutation analysis of the Fanconi anemia gene FACC.. PubMed. 54(4). 595–601. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026